Topic: infectious diseases

Improved safeguards needed at biosafety labs

More needs to be done to improve safety and public accountability at the nation’s high-containment biosafety laboratories that work with deadly viruses and bacteria, according to Marc Lipsitch, professor of epidemiology and director of the Center for Communicable Disease Dynamics at Harvard…

Tackling malaria using the art of deception

May 27, 2015 — Francisco Cai could have parlayed his Stanford computer science degrees into opportunities developing a smartphone app or increasing a website’s ad revenues. Instead, he sought out a way to use his formidable coding skills to tackle problems affecting…

Understanding the social context of Ebola

April 10, 2015 — Theresa Betancourt, ScD ’03, associate professor of child health and human rights, directs the Research Program on Children and Global Adversity, based at the Harvard T.H. Chan School of Public Health's Department of Global Health and Population. She has…

Dealing with parents’ mistrust of vaccines

As the Disneyland measles outbreak continues to make headlines and fuel public debate, health professionals seek more effective ways to convince parents who mistrust vaccines to get their children vaccinated, according to Barry R. Bloom, Harvard University Distinguished Service Professor and Joan…

Fighting to end polio in Syria

After helping bring international attention to an emerging polio epidemic in Syria, Annie Sparrow, MPH '04, has been working for the past year to help the country’s medical workers learn to diagnose and treat the disease. An Australian-born physician and professor of…

New molecular target identified for treating cerebral malaria

For immediate release: January 30, 2015 Boston, MA – A drug already approved for treating other diseases may be useful as a treatment for cerebral malaria, according to researchers at Harvard T. H. Chan School of Public Health. They discovered a novel link between…

Dangerous pathogen research should be stopped—for good

Research on extremely dangerous pathogens—on “pause” in the U.S. as scientific panels consider whether or not to continue federal funding for such work—should be stopped altogether, says Marc Lipsitch, professor of epidemiology and director of the Center for Communicable Disease Dynamics at…